People and Business News – 6/23
The latest people and business news from the past month, all in one place.
People News
DM Clinical Research announced the hiring of Wes Bonner as VP of Strategic Relationships. Previously, Bonner held various leadership roles with Meridian Clinical Research for 10 years.
HeartcoR Solutions announced the promotion of two company executives. Cesar Patino will start as director of project management and Henry Flores will move into a newly created position as director of device and application portfolio.
Emmes announced the addition of Kristin Judge as chief growth officer, a newly created role. Previously, she served as head of CRO and clinical data management systems sales at Veeva Systems, leading a global team responsible for more than 200 customers across both the CRO and biotech sectors.
Phastar announced that statistics manager Stephen Corson has been chosen to receive the DIA 2023 Global Inspire Award for Community Engagement and advancing thought leadership within the membership community.
DM Clinical Research announced the recruitment of Stephanie Ailey as VP of business development. Prior to joining DM Clinical Research, she served as VP of business development with both Velocity Clinical Research and Meridian Clinical Research.
Beaconcure announced the appointment of Rick Riegel as board chairman. Additionally, Riegel worked to assemble an advisory board that includes Craig Lipset, John Oidtman, and Irving Dark.
Business News
Clario announced the implementation of over 30 new AI solutions, aiming to provide faster data analysis.
Worldwide Clinical Trials expanded its site alliance collaboration with new partners across North America and Europe.
Aixial Group has fully integrated Cmed and Larix to become a mid-size CRO with more than 1,000 employees.
Centricity Research has announced a major clinical trials investment from Trinity Hunt Partners.
Almac Group announced a 14.3% rise in revenue, marking its most financially successful year to date.
WCG announced a company rebrand, aimed at elevating the company’s identity and supporting their mission of improving lives through accelerating research.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
